Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
EllisDon Wins Two CCPPP 2024 National Awards for Innovation and Excellence in P3s
-
Acumen Pharmaceuticals Appoints Dr. Amy Schacterle as Chief Regulatory Officer & Head of Quality
-
Entrée Resources Announces Third Quarter 2024 Results
-
LifeMD® Launches Affiliated Pharmacy to Drive End-to-End Patient Care and Operational Efficiency
-
Reviva to Present Positive Speech Latency Data for Brilaroxazine in Schizophrenia From the Phase 3 RECOVER Trial at the CNS Summit 2024
-
Lexicon Pharmaceuticals to Participate in the Jefferies London Global Healthcare Conference
-
Kawasaki Selects Cerence to Transform the Rider Experience Across Its Motorcycle Lineup
-
Janover Reports Third Quarter 2024 Financial Results and Provides Business Update
-
Madrigal Pharmaceuticals, Inc. Announces Participation at Three Upcoming Investor Conferences
-
Protara Therapeutics to Present at the Guggenheim Inaugural Healthcare Innovation Conference
-
Mobivity Schedules Third Quarter 2024 Conference Call for Thursday, November 14, 2024
-
Humacyte to Present Third Quarter Financial Results and Provide Corporate Update on November 8, 2024
-
Keros Therapeutics to Present at the Guggenheim Healthcare Innovation Conference
-
Twin Disc Announces First Quarter Results
-
Twin Disc Approves a Quarterly Cash Dividend
-
Taysha Gene Therapies to Release Third Quarter 2024 Financial Results and Host Conference Call and Webcast On November 13
-
Recce Pharmaceuticals Advances Patient Dosing to Final Stages in Phase II Trial for Acute Bacterial Skin and Skin Structure Infections
-
NV5 Awarded $7 Million Lake Havasu Bridge and Roadway Infrastructure Improvement Contract
-
iCAD to Attend 15th Annual Craig-Hallum Alpha Select Conference
-
VERSES Welcomes Business Solutions Provider Prodigii to Genius™ Beta
-
Clean Energy Technologies, Inc. Plans to Expand into Cryptocurrency Mining and Artificial Intelligence Datacenter Sectors
-
Barinthus Bio Reports Third Quarter 2024 Update on Corporate Developments and Financial Results
-
NANO Nuclear Energy Announces Investment, Strategic Collaboration and Future Fuel Purchasing Agreement with LIS Technologies Inc., the Only U.S.-Origin and Patented Laser-Based Uranium Enrichment Comp
-
Pliant Therapeutics to Participate in the Stifel Healthcare Conference
-
Acumen Pharmaceuticals Appoints Dr. Amy Schacterle as Chief Regulatory Officer & Head of Quality
-
NewAmsterdam Pharma Provides Corporate Update and Reports Third Quarter Financial Results
-
The RoyaLand Company Approved to Trade on OTCQB® Venture Market
-
Aemetis to Review Third Quarter 2024 Financial Results on November 12, 2024
-
Spectral AI Announces Plan to Spin Off Spectral IP Subsidiary Focused on Intellectual Property Investments and Monetization
-
Monarch Private Capital Closes LIHTC Equity Financing for Patterson Point in Goleta, CA
-
Karat Packaging Board Declares Increase in Quarterly Cash Dividend
-
Cabaletta Bio to Participate in Guggenheim’s Inaugural Healthcare Innovation Conference
-
Liquidia Corporation to Report Third Quarter 2024 Financial Results on November 13, 2024
-
Edible Garden Schedules Third Quarter 2024 Financial Results and Business Update Conference Call
-
PDS Biotech to Announce Third Quarter Financial Results on November 14, 2024 at 8:30 a.m. Eastern Time
-
ARS Pharmaceuticals Announces Conference Call and Webcasts for its Third Quarter 2024 Financial Results and Presentations at Upcoming Conferences
-
red violet to Participate in the Southwest IDEAS Investor Conference
-
Rhythm Pharmaceuticals Announces Participation in Upcoming Investor Conferences
-
Fulcrum Therapeutics to Host Third Quarter 2024 Financial Results Conference Call and Webcast on Wednesday, November 13, 2024 at 8:00 a.m. ET
-
Inspire Medical Systems, Inc. to Present at Jefferies London Healthcare Conference
-
EDAP to Participate in the 2024 Jefferies London Healthcare Conference
-
Thumzup Finalizing Video Capabilities to Enable Integration with Instagram Reels
-
Form 8.3 - [ECKOH PLC - 05 11 2024] - (CGWL)
-
Major shareholder announcement from Nordic Compound Invest A/S
-
Invesco Ltd: Form 8.3 - Anglogold Ashanti PLC; Public dealing disclosure
-
Alterity Therapeutics Announces New Publication Describing Novel Mechanism of Action for ATH434
-
Latin Metals Vests 71% Ownership of Key Argentine Gold-Silver Exploration Assets with Potential for High-Grade Discoveries
-
Invesco Ltd: Form 8.3 - International Paper Company; Public dealing disclosure
-
FlexShopper Partners with Aftermarket Auto Parts Alliance to Revolutionize Automotive Care Financing
-
Angus Gold Continues to define New Gold Zone at Dorset West, Intersects 2.3 g/t Au over 9.8 metres including 8.2 g/t Au over 2.1 metres, Golden Sky Project, Wawa

